Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.380
+0.030 (2.22%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aytu BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Net Income | -6.25 | -15.84 | -17.05 | -108.78 | -58.29 | -13.62 | Upgrade
|
Depreciation & Amortization | 7.86 | 8.27 | 8.82 | 10.15 | 9.2 | 5.71 | Upgrade
|
Other Amortization | 0.48 | 0.6 | 0.56 | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 5.71 | 75.46 | 12.83 | 0.2 | Upgrade
|
Stock-Based Compensation | 2.36 | 2.91 | 6.05 | 5.25 | 3.57 | 1.08 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | 0.61 | 0.41 | Upgrade
|
Other Operating Activities | -1.9 | 7.33 | -3.4 | -0.03 | 4.44 | -8.27 | Upgrade
|
Change in Accounts Receivable | 7.48 | 5.32 | -7.15 | 6.53 | 1.54 | -3.56 | Upgrade
|
Change in Inventory | -1.45 | -2.91 | -3.61 | 1.3 | 2.79 | -8.22 | Upgrade
|
Change in Accounts Payable | -0.68 | -2.88 | 2.38 | -7.68 | -3.25 | -1.38 | Upgrade
|
Change in Other Net Operating Assets | -8.33 | -4.19 | 2.58 | -11.01 | 0.6 | -0.72 | Upgrade
|
Operating Cash Flow | -2.37 | -1.39 | -5.13 | -28.82 | -25.96 | -28.37 | Upgrade
|
Capital Expenditures | -0.14 | - | - | - | -2.34 | - | Upgrade
|
Cash Acquisitions | - | - | - | -3.18 | -0.48 | -5.66 | Upgrade
|
Other Investing Activities | -0.25 | -0.33 | -0.12 | -0.07 | 0.04 | 0.01 | Upgrade
|
Investing Cash Flow | 0.13 | -0.33 | -0.12 | -3.25 | -2.78 | -5.66 | Upgrade
|
Short-Term Debt Issued | - | 0.83 | - | - | 51.21 | - | Upgrade
|
Long-Term Debt Issued | - | 13 | - | 15 | - | 3.19 | Upgrade
|
Total Debt Issued | 15.71 | 13.83 | - | 15 | 51.21 | 3.19 | Upgrade
|
Short-Term Debt Repaid | - | - | -2.25 | -4.12 | -53.98 | - | Upgrade
|
Long-Term Debt Repaid | - | -15.72 | -0.1 | -16.1 | -0.97 | -19.44 | Upgrade
|
Total Debt Repaid | -15.82 | -15.72 | -2.35 | -20.22 | -54.95 | -19.44 | Upgrade
|
Net Debt Issued (Repaid) | -0.11 | -1.89 | -2.35 | -5.22 | -3.74 | -16.25 | Upgrade
|
Issuance of Common Stock | 3.47 | 3.47 | 15.58 | 11.69 | 40.15 | 92.72 | Upgrade
|
Other Financing Activities | -0.98 | -2.84 | -4.36 | -4.94 | -6.09 | -5.4 | Upgrade
|
Financing Cash Flow | 2.38 | -1.26 | 8.87 | 1.53 | 30.31 | 71.07 | Upgrade
|
Net Cash Flow | 0.14 | -2.98 | 3.63 | -30.54 | 1.57 | 37.04 | Upgrade
|
Free Cash Flow | -2.5 | -1.39 | -5.13 | -28.82 | -28.31 | -28.37 | Upgrade
|
Free Cash Flow Margin | -3.14% | -1.71% | -4.78% | -29.82% | -43.13% | -102.69% | Upgrade
|
Free Cash Flow Per Share | -0.44 | -0.25 | -1.54 | -19.61 | -33.80 | -125.57 | Upgrade
|
Cash Interest Paid | 3.05 | 4.04 | 3.81 | 3.15 | 1.25 | 1.04 | Upgrade
|
Cash Income Tax Paid | 1.81 | 1.61 | - | - | - | - | Upgrade
|
Levered Free Cash Flow | 7.31 | 4.81 | 2.67 | -17.72 | 15.64 | -5.25 | Upgrade
|
Unlevered Free Cash Flow | 9.65 | 7.2 | 5.21 | -17.71 | 15.64 | -5.25 | Upgrade
|
Change in Net Working Capital | -0.46 | 2.64 | 1.95 | 9.29 | -29.11 | 0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.